LYME ASSOCIATION FRANCE
SCRISOARE CATRE MINISTRUL SANATATII DIN FRANTA
BP 100496 / Arcueil - 94410 POST ARCUEIL PDC
email: contact@francelyme.fr • Web: www.francelyme.fr
5/11
5.2.1. Polemics on the chronicity of the disease
We are currently witnessing a radicalization of discourse "anti-chronicity" of Lyme borreliosis, of
from our two National Reference Centres (Pasteur Institute of Infectious Diseases and Hospital Civil Service
At present, more and more newspaper articles and television reports appear, where the point of
for the sick and infectious disease confront. Despite all this, the confrontation lasted about
reliability of serology and mode of therapeutic care and disseminated forms
chronic Lyme disease.
Faced with this situation, patients gather more and more associations and attempt to alert
government. Unfortunately, these warnings have so far met with little response. Worse, organizations
patients are often accused by the National Reference Centres maintain a psychosis
around the subject.
These associations often find that doctors change their opinion on chronicity and
support of borreliosis, lorsqu'eux own-or someone in their immediate environment-are
affected by this infection. They then join and eagerly support patients' associations.
5.2.2. Inconsistency of treatment of Lyme disease with measures
current restrictive antibiotic prescribing
The campaign "Antibiotics are not automatic" and that the measures taken to limit
antibiotic prescriptions (physician compensation to performance) [9], although useful to limit
drifts in the treatment of common diseases, has been very detrimental to treatment
effective Lyme disease which, as we have seen, usually requires antibiotics very
Early and long-term.
The absence of antibiotic treatment led to a proliferation of Borrelia bacteria in the body
sick and causes of rheumatism, paralysis, etc.., and often leads to the classification of the patient
disabled person.
In addition, a financial point of view, it should be noted that the cost of antibiotics for
rather long treatment is significantly lower than painkillers or antidepressants
given for years. In addition, early treatment (primary stage) is much less expensive than
delayed treatment, longer and more intensive.
Examples of costs:
• Doxycycline 200 mg / day: 15,54 € / month
• Minocycline 200 mg / day: € 28.37 / month (hospital use only)
• Amoxicillin 3 g / day: € 33.94 / month
• Ceftriaxone IV in: 456 € / month, excluding the cost nursing
Finally, a treatment for the patient to return to normal life saves the state of loads
(Sickness benefits, allowances 'disabled person' or disability pension).
No comments:
Post a Comment